Aerpio Pharmaceuticals, Inc.
MULTISPECIFIC ANTIBODIES THAT TARGET HPTP-B (VE-PTP) AND VEGF
Last updated:
Abstract:
The disclosure provides compositions comprising multi-specific compounds, including a compound that targets a phosphatase and a receptor tyrosine kinase agonist. Also provided are methods for the treatment of conditions associated with angiogenesis, comprising administering a multi-specific compound that targets a phosphatase and a receptor tyrosine kinase agonist.
Status:
Application
Type:
Utility
Filling date:
23 Sep 2019
Issue date:
26 Mar 2020